Hangzhou Meiya Pharmaceutical Co., Ltd.-Industry Trends

News Dynamics

Provides you with the latest company and industry information

Stay up to date with the latest company news and upcoming events

ADP Pathway Uncovers Mechanism Behind Anti-VEGF Treatment Escape, Paving the Way for New Ophthalmic Drugs

넶0 2026-06-10
NMN’s Liver Protection Validated: Targeting Hamp to Improve Alcohol-Induced Hepatic Steatosis

넶2 2026-06-03
Directed Engineering of Escherichia coli Enables Efficient Biosynthesis of Cytidine 5'-Monophosphate (CMP)

넶4 2026-05-27
Major Breakthrough in Cancer Metabolism: UMP Emerges as a Novel Key Target for Precision Gastric Cancer Therapy

넶4 2026-05-20
Milestone Discovery: AMP Acts as an Epigenetic Switch to Precisely Drive White Fat Breakdown

넶27 2026-05-13
From Nutrient to Signaling Molecule: Uridine Ushers in a New Era of Reproductive Anti-Aging

넶27 2026-05-09
New Mechanism of FAD-Mediated FSP1 Stabilization Uncovered: Vitamin B2 Metabolism Emerges as a Novel Anticancer Target

넶16 2026-04-29
Green Manufacturing Breakthrough: Chemoenzymatic Synthesis of Pseudouridine Triphosphate Cuts mRNA Vaccine Costs

넶19 2026-04-22

About Meiya

Product Center

Service Support

Related Links

Address

Headquarters: Hangzhou Meiya Pharmaceutic

al Co., Ltd.

Room 101, Building 12, Yinhai Science and Tech

nology Innovation Center, 501 Fucheng Road,

Xiasha Street, Qiantang District, Hangzhou City,

Zhejiang Province

Sales Company: Shanghai Nucleotide Biotec

hnology Co., Ltd.

Production base: Meiya Pharmaceutical Hai

an Co., Ltd.

Copyright©2025 Hangzhou Meiya Pharmaceutical Co., Ltd.